Literature DB >> 17569617

Green tea polyphenols: biology and therapeutic implications in cancer.

Sharmila Shankar1, Suthakar Ganapathy, Rakesh K Srivastava.   

Abstract

Multiple lines of evidence, mostly from population-based studies, suggest that green tea consumption is associated with reduced risk of several human malignancies such as cancer and diabetes. Epigallocatechin-3-gallate (EGCG), a major polyphenol found in green tea, is a widely studied chemopreventive agent with potential anticancer activity. Green tea polyphenols inhibit angiogenesis and metastasis, and induce growth arrest and apoptosis through regulation of multiple signaling pathways. Specifically, EGCG regulates expression of VEGF, matrix metalloproteinases, uPA, IGF-1, EGFR, cell cycle regulatory proteins and inhibits NFk B, PI3-K/Akt, Ras/Raf/MAPK and AP-1 signaling pathways, thereby causing strong cancer chemopreventive effects. This review discusses the molecular mechanisms of green tea polyphenols and their therapeutic implications in cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17569617     DOI: 10.2741/2435

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  41 in total

1.  Effects of tea polyphenols on proliferation and apoptosis of cadmium-transformed cells.

Authors:  Min Wang; Yi-Xiong Lei
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Green tea and PUMA: a deadly combination?

Authors:  Crissy Dudgeon; Jian Yu
Journal:  Cancer Biol Ther       Date:  2008-05-21       Impact factor: 4.742

3.  Inhibition of proliferation and gene expression regulation by (-)-epigallocatechin-3-gallate in human synovial sarcoma cells.

Authors:  Yongming Sun; Haibin Wang; Fanguo Lin; Jun Hua; Gaoli Zhou
Journal:  Med Oncol       Date:  2010-05-18       Impact factor: 3.064

4.  Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis in Ec9706 and Eca109 esophageal carcinoma cells.

Authors:  Liang Liu; Jing Zuo; Guangda Wang
Journal:  Oncol Lett       Date:  2017-08-03       Impact factor: 2.967

5.  Drinking green tea modestly reduces breast cancer risk.

Authors:  Martha J Shrubsole; Wei Lu; Zhi Chen; Xiao Ou Shu; Ying Zheng; Qi Dai; Qiuyin Cai; Kai Gu; Zhi Xian Ruan; Yu-Tang Gao; Wei Zheng
Journal:  J Nutr       Date:  2008-12-11       Impact factor: 4.798

Review 6.  Caffeine in tea Camellia sinensis--content, absorption, benefits and risks of consumption.

Authors:  A Gramza-Michałowska
Journal:  J Nutr Health Aging       Date:  2014       Impact factor: 4.075

7.  (-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-κB p65 inactivation.

Authors:  Ya-Jun Li; Shun-Long Wu; Song-Mei Lu; Fang Chen; Ying Guo; Sheng-Min Gan; Yan-Long Shi; Shuang Liu; Shao-Lin Li
Journal:  Tumour Biol       Date:  2014-12-07

8.  Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft.

Authors:  Emilie Allard; Delphine Jarnet; Anne Vessières; Sandrine Vinchon-Petit; Gérard Jaouen; Jean-Pierre Benoit; Catherine Passirani
Journal:  Pharm Res       Date:  2009-11-12       Impact factor: 4.200

9.  The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.

Authors:  Su-Ni Tang; Chandan Singh; Dara Nall; Daniel Meeker; Sharmila Shankar; Rakesh K Srivastava
Journal:  J Mol Signal       Date:  2010-08-18

10.  EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition.

Authors:  Yong Zhang; Shao-Xiang Wang; Ji-Wei Ma; Hai-Ying Li; Jie-Cheng Ye; Si-Ming Xie; Bin Du; Xue-Yun Zhong
Journal:  J Neurooncol       Date:  2014-08-31       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.